Patents by Inventor Aritoshi Iida

Aritoshi Iida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140051074
    Abstract: An object of the present invention is to identify a novel single nucleotide polymorphism (SNP) associated with the onset and the advancement of inflammatory diseases such as myocardial infarction. The present invention provides a method for judging an inflammatory disease which comprises detecting at least 1 type of genetic polymorphism existing in at least one gene selected from the group consisting of the LBP-32 gene, the TSBP gene, and the WAP gene.
    Type: Application
    Filed: July 30, 2013
    Publication date: February 20, 2014
    Applicant: RIKEN
    Inventors: Toshihiro TANAKA, Yusuke NAKAMURA, Yozo OHNISHI, Kouichi OZAKI, Aritoshi IIDA, Masatsugu HORI
  • Patent number: 8518644
    Abstract: An object of the present invention is to identify a novel single nucleotide polymorphism (SNP) associated with the onset and the advancement of inflammatory diseases such as myocardial infarction. The present invention provides a method for judging an inflammatory disease which comprises detecting at least 1 type of genetic polymorphism existing in at least one gene selected from the group consisting of the LBP-32 gene, the TSBP gene, and the WAP gene.
    Type: Grant
    Filed: July 6, 2006
    Date of Patent: August 27, 2013
    Assignee: Riken
    Inventors: Toshihiro Tanaka, Yusuke Nakamura, Yozo Ohnishi, Koichi Ozaki, Aritoshi Iida, Masatsugu Hori
  • Patent number: 8158351
    Abstract: It is an object of the present invention to provide a method for determining inflammatory diseases including myocardial infarction as a typical example, which involves identifying polymorphisms associated with myocardial infarction and using the gene polymorphisms, an oligonucleotide that can be used for the method, a kit for diagnosing inflammatory diseases, a therapeutic agent for inflammatory diseases, and the like. The present invention provides a method for determining an inflammatory disease, which comprises detecting at least one type of gene polymorphism existing in a proteasome subunit ? type 6 gene.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: April 17, 2012
    Assignee: Riken
    Inventors: Toshihiro Tanaka, Yusuke Nakamura, Aritoshi Iida, Kouichi Ozaki, Masatsugu Hori
  • Patent number: 8048625
    Abstract: A single nucleotide polymorphism occurring on a leptin receptor gene is analyzed and an inflammatory disease is examined on the basis of the analytical data. Further, a substance capable of changing the interaction between the leptin receptor and galectin-2 is selected to thereby screen a remedy for an inflammatory disease.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: November 1, 2011
    Assignee: Riken
    Inventors: Toshihiro Tanaka, Koichi Ozaki, Aritoshi Iida, Masatsugu Hori, Yozo Ohnishi, Yusuke Nakamura
  • Patent number: 8026063
    Abstract: A gene polymorphism on a Toll-like receptor gene is analyzed and an inflammatory disease is examined based on the results of the analysis. A remedy for an inflammatory disease is screened by selecting a substance capable of altering the interaction between Toll-like receptor and galectin-2.
    Type: Grant
    Filed: January 11, 2006
    Date of Patent: September 27, 2011
    Assignee: Riken
    Inventors: Toshihiro Tanaka, Koichi Ozaki, Aritoshi Iida, Masatsugu Hori, Yusuke Nakamura
  • Publication number: 20110097711
    Abstract: An object of the present invention is to identify a novel single nucleotide polymorphism (SNP) associated with the onset and the advancement of inflammatory diseases such as myocardial infarction. The present invention provides a method for judging an inflammatory disease which comprises detecting at least 1 type of genetic polymorphism existing in at least one gene selected from the group consisting of the LBP-32 gene, the TSBP gene, and the WAP gene.
    Type: Application
    Filed: January 6, 2006
    Publication date: April 28, 2011
    Applicant: RIKEN
    Inventors: Toshihiro Tanaka, Yusuke Nakamura, Yozo Ohnishi, Koichi Ozaki, Aritoshi Iida, Masatsugu Hori
  • Publication number: 20100323346
    Abstract: A single nucleotide polymorphism occurring on a leptin receptor gene is analyzed and an inflammatory disease is examined on the basis of the analytical data. Further, a substance capable of changing the interaction between the leptin receptor and galectin-2 is selected to thereby screen a remedy for an inflammatory disease.
    Type: Application
    Filed: December 22, 2005
    Publication date: December 23, 2010
    Applicant: RIKEN
    Inventors: Toshihisa Tanaka, Koichi Ozaki, Aritoshi Iida, Masatsugu Hori, Yozo Ohnishi, Yusuke Nakamura
  • Publication number: 20100233684
    Abstract: It is an object of the present invention to provide a method for determining inflammatory diseases including myocardial infarction as a typical example, which involves identifying polymorphisms associated with myocardial infarction and using the gene polymorphisms, an oligonucleotide that can be used for the method, a kit for diagnosing inflammatory diseases, a therapeutic agent for inflammatory diseases, and the like. The present invention provides a method for determining an inflammatory disease, which comprises detecting at least one type of gene polymorphism existing in a proteasome subunit ? type 6 gene.
    Type: Application
    Filed: June 15, 2007
    Publication date: September 16, 2010
    Applicant: RIKEN
    Inventors: Toshihiro Tanaka, Yusuke Nakamura, Aritoshi Iida, Kouichi Ozaki, Masatsugu Hori
  • Patent number: 7754422
    Abstract: The object of the present invention is to determine inflammatory diseases such as myocardial infarction by identifying single nucleotide polymorphisms (SNPs) associated with myocardial infarction and utilizing these SNPs. The present invention provides a method for determining an inflammatory disease, which comprises detecting at least one gene polymorphism existing in at least one gene selected from the group consisting of a lymphotoxin-? (LT-?) gene, an I Kappa B-like (IKBL) gene, and a BAT1 gene; an oligonucleotide used in said method; a kit for diagnosing an inflammatory disease which comprises said oligonucleotide; and use thereof. The present invention further provides a method for treating an inflammatory disease; and a method for screening for a therapeutic agent for an inflammatory disease.
    Type: Grant
    Filed: August 8, 2003
    Date of Patent: July 13, 2010
    Assignee: Riken
    Inventors: Toshihiro Tanaka, Yozo Ohnishi, Koichi Ozaki, Aritoshi Iida, Yusuke Nakamura, Masatsugu Hori
  • Publication number: 20080280293
    Abstract: A gene polymorphism on a Toll-like receptor gene is analyzed and an inflammatory disease is examined based on the results of the analysis. A remedy for an inflammatory disease is screened by selecting a substance capable of altering the interaction between Toll-like receptor and galectin-2.
    Type: Application
    Filed: January 11, 2006
    Publication date: November 13, 2008
    Applicant: Riken
    Inventors: Toshihiro Tanaka, Koichi Ozaki, Aritoshi Iida, Masatsugu Hori, Yusuke Nakamura
  • Publication number: 20070190528
    Abstract: An object of the present invention is to identify a novel single nucleotide polymorphism (SNP) associated with the onset and development of inflammatory diseases such as myocardial infarction. The present invention provides a method for judging inflammatory diseases which comprises detecting at least one gene polymorphism in the galectin-2 gene.
    Type: Application
    Filed: August 18, 2004
    Publication date: August 16, 2007
    Applicants: RIKEN
    Inventors: Toshihiro Tanaka, Yozo Ohnishi, Kouichi Ozaki, Aritoshi Iida, Masatsugu Hori, Yusuke Nakamura
  • Publication number: 20070105128
    Abstract: The present invention relates to genetic polymorphism data, compositions and methods for detecting genetic polymorphisms, methods for evaluating drugs using genetic polymorphisms and screening methods for drugs.
    Type: Application
    Filed: March 22, 2006
    Publication date: May 10, 2007
    Inventors: Yusuke Nakamura, Akihiro Sekine, Aritoshi Iida, Susumu Saito
  • Publication number: 20060234230
    Abstract: A method for detecting a genetic polymorphism(s) in a gene encoding cytochrome P450 using as oligonucleotide probes and/or oligonucleotide primers at least one sequence selected from the group consisting of an at least 13 nucleotide sequence within any of the nucleotide sequences as shown in SEQ ID NOS: 1 through 215, said at least 13 nucleotide sequence containing the 21st nucleotide, or a sequence complementary to said at least 13 nucleotide sequence.
    Type: Application
    Filed: May 29, 2003
    Publication date: October 19, 2006
    Inventors: Yusuke Nakamura, Akihiro Sekine, Aritoshi Iida, Susumu Saito
  • Publication number: 20060147920
    Abstract: The object of the present invention is to determine inflammatory diseases such as myocardial infarction by identifying single nucleotide polymorphisms (SNPs) associated with myocardial infarction and utilizing these SNPs. The present invention provides a method for determining an inflammatory disease, which comprises detecting at least one gene polymorphism existing in at least one gene selected from the group consisting of a lymphotoxin-? (LT-?) gene, an I Kappa B-like (IKBL) gene, and a BAT1 gene; an oligonucleotide used in said method; a kit for diagnosing an inflammatory disease which comprises said oligonucleotide; and use thereof. The present invention further provides a method for treating an inflammatory disease; and a method for screening for a therapeutic agent for an inflammatory disease.
    Type: Application
    Filed: August 8, 2003
    Publication date: July 6, 2006
    Inventors: Toshihiro Tanaka, Yozo Ohnishi, Koichi Ozaki, Aritoshi Iida, Yusuke Nakamura, Masatsugu Hori